Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
|
|
GE HealthCare Technologies Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Rott Roland (CEO, Ultrasound) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Paid exercise price by delivering 1,630 shares
@ $76.19, valued at
$124.2k
|
|
| 08/07/2023 |
4
| O'Neill Kevin Michael (CEO, PDx) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Paid exercise price by delivering 1,532 shares
@ $76.19, valued at
$116.7k
|
|
| 08/07/2023 |
4
| Makela Jan (CEO, Imaging) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Paid exercise price by delivering 4,596 shares
@ $76.19, valued at
$350.2k
|
|
| 08/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
4
| Makela Jan (CEO, Imaging) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Paid exercise price by delivering 1,929 shares
@ $80.36, valued at
$155k
|
|
| 06/12/2023 |
4
| Rott Roland (CEO, Ultrasound) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Sold 2,473 shares
@ $77.37, valued at
$191.3k
|
|
| 06/12/2023 |
4
| GENERAL ELECTRIC CO (10% Owner) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Disposed of 25,000,000 shares
@ $0 |
|
| 06/08/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/05/2023 |
4
| SACCARO JAMES (CFO) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 43,843 shares
@ $0
Granted 11,900 shares
@ $0
Granted 5,950 shares
@ $0
Granted 36,176 options to buy
@ $79.83, valued at
$2.9M
Granted 54,472 options to buy
@ $79.83, valued at
$4.3M
|
|
| 06/05/2023 |
3
| SACCARO JAMES (CFO) has filed a Form 3 on GE HealthCare Technologies Inc. |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/25/2023 |
4
| Mihaljevic Tomislav (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| Madden Anne T (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0
Granted 1,214 shares
@ $0 |
|
| 05/25/2023 |
4
| CULP H LAWRENCE JR (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| Hochman Rodney F (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0
Granted 1,214 shares
@ $0 |
|
| 05/25/2023 |
4
| LESJAK CATHERINE A (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| LAVIZZO-MOUREY RISA J (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| HOWELL LLOYD JR (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| Yang Watkin Phoebe L. (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0 |
|
| 05/25/2023 |
4
| Stromberg William J (Director) has filed a Form 4 on GE HealthCare Technologies Inc.|
Txns:
| Granted 3,584 shares
@ $0
Granted 1,408 shares
@ $0 |
|
| 05/25/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/10/2023 |
SC 13G
| Capital Research Global Investors reports a 10.5% stake in GE HealthCare Technologies Inc. |
| 05/09/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|